STERIGENICS DENMARK A/S: Financial statements 2024
CVR: 26299691
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
STERIGENICS DENMARK A/S (CVR 26299691) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 44,413,648 and a net result of DKK 25,507,602 compared with DKK 18,952,504 the year before. That is an increase of 30.5% compared with the year before. Equity in the 2024 report amounted to DKK 68,865,021. The solvency ratio was 90.3%. The company had 45 employees in the financial year.
- Gross Profit
- DKK 44,413,648
- Profit/Loss
- DKK 25,507,602
- Equity
- DKK 68,865,021
- Total Assets
- DKK 76,246,695
- Employees
- 45
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 44.4M | 25.5M | 68.9M | 45 |
| 2023 | - | 34M | 19M | 121.7M | 42 |
| 2022 | - | 37M | 20.8M | 102.7M | 40 |
| 2021 | - | 33.2M | 19.8M | 81.9M | 33 |
| 2020 | - | 23.9M | 12.9M | 62.1M | 34 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
As of December 2, 2024, is registered as an owner of STERIGENICS DENMARK A/S with an ownership share of 100%.
STERIGENICS DENMARK A/S has published its annual report for 2023. Gross profit came to DKK 34,023,303, and the net result was DKK 18,952,504.
About STERIGENICS DENMARK A/S
STERIGENICS DENMARK A/S is a Danish company of the type Aktieselskab based in Espergærde, founded in 2001. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named IBA S&I (DENMARK) A/S. The management consists of Maja Nøddekær. The board consists of Robin Van Der Bergh (chair), Maja Nøddekær and Ronald Victor Asselberghs. The company is owned by Nelson Labs BV. The company has 51 employees (2026). In 2025, the company reported a gross profit of DKK 45,023,268 and a net result of DKK 24,334,784 compared with DKK 25,507,602 the year before. Equity in the 2025 report amounted to DKK 44,335,784.